Abits
ABTS
Digihost Technology
DGHI
Argo Blockchain
ARBK
4
FRMO CORP
FRMO
5
The9 Ltd
NCTY
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.